Literature DB >> 27624165

Exploring ligand dissociation pathways from aminopeptidase N using random acceleration molecular dynamics simulation.

Ya Liu1, GuoGang Tu2, XiaoPing Lai1, BinHai Kuang1, ShaoHua Li1.   

Abstract

Aminopeptidase N (APN) is a zinc-dependent ectopeptidase involved in cell proliferation, secretion, invasion, and angiogenesis, and is widely recognized as an important cancer target. However, the mechanisms whereby ligands leave the active site of APN remain unknown. Investigating ligand dissociation processes is quite difficult, both in classical simulation methods and in experimental approaches. In this study, random acceleration molecular dynamics (RAMD) simulation was used to investigate the potential dissociation pathways of ligand from APN. The results revealed three pathways (channels A, B and C) for ligand release. Channel A, which matches the hypothetical channel region, was the most preferred region for bestatin to dissociate from the enzyme, and is probably the major channel for the inner bound ligand. In addition, two alternative channels (channels B and C) were shown to be possible pathways for ligand egression. Meanwhile, we identified key residues controlling the dynamic features of APN channels. Identification of the dissociation routes will provide further mechanistic insights into APN, which will benefit the development of more promising APN inhibitors. Graphical Abstract The release pathways of bestatin inside active site of aminopeptidase N were simulated using RAMD simulation.

Entities:  

Keywords:  Aminopeptidase N; Dissociation pathways; Molecular dynamics

Mesh:

Substances:

Year:  2016        PMID: 27624165     DOI: 10.1007/s00894-016-3105-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  28 in total

1.  Enkephalin degradating enzymes in pheochromocytoma patients.

Authors:  Tihomir Balog; Tatjana Marotti; Visnja Sverko; Miljenko Marotti; Ivan Krolo; Boris Rocic; Nikola Karapanda
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Single-molecule pulling simulations can discern active from inactive enzyme inhibitors.

Authors:  Francesco Colizzi; Remo Perozzo; Leonardo Scapozza; Maurizio Recanatini; Andrea Cavalli
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

3.  Redesigning dehalogenase access tunnels as a strategy for degrading an anthropogenic substrate.

Authors:  Martina Pavlova; Martin Klvana; Zbynek Prokop; Radka Chaloupkova; Pavel Banas; Michal Otyepka; Rebecca C Wade; Masataka Tsuda; Yuji Nagata; Jiri Damborsky
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

4.  Efficient mapping of ligand migration channel networks in dynamic proteins.

Authors:  Tu-Liang Lin; Guang Song
Journal:  Proteins       Date:  2011-06-02

5.  Exploring inhibitor release pathways in histone deacetylases using random acceleration molecular dynamics simulations.

Authors:  Subha Kalyaanamoorthy; Yi-Ping Phoebe Chen
Journal:  J Chem Inf Model       Date:  2012-02-07       Impact factor: 4.956

6.  Ligand entry and exit pathways in the beta2-adrenergic receptor.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Biol       Date:  2009-08-06       Impact factor: 5.469

7.  The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer.

Authors:  Stacy Carl-McGrath; Uwe Lendeckel; Matthias Ebert; Alexandra-Beatrice Wolter; Albert Roessner; Christoph Röcken
Journal:  Int J Oncol       Date:  2004-11       Impact factor: 5.650

8.  Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.

Authors:  H Fujii; M Nakajima; I Saiki; J Yoneda; I Azuma; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

9.  Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.

Authors:  Astrid Kehlen; Uwe Lendeckel; Henning Dralle; Jürgen Langner; Cuong Hoang-Vu
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

10.  CD13/aminopeptidase N in collagen vascular diseases.

Authors:  Hirohumi Dan; Kenji Tani; Kayoko Hase; Teruki Shimizu; Hiroyuki Tamiya; Yanjmaa Biraa; Luping Huang; Hiroaki Yanagawa; Saburo Sone
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.